Content Please enter your email address and password:

Forgotten your password? Click here.

We are the Pharmacy Law & Ethics Association
PLEA

Latest News

Results page: 1 2 3 4 ... 26 27 28 [Next]

Flaws in control of "legal highs"

Posted: Thursday, August 31st, 2017

Measures to control so-called "legal highs" were introduced last year but in two recent court cases concerning recreational use of nitrous oxide gas, the law proved inadequate to secure convictions. PLEA readers may like to view a fairly comprehensive account from BBC news here. (JW on behalf of Ian Simpson).

Provision of info on "health service products"

Posted: Wednesday, August 30th, 2017

The DH is seeking views on legal requirements for the provision of information related to the sales and purchases of health service products. These will cover medicines, medical supplies and other related products used in the NHS. This consultation is linked to the earlier one on changes to the PPRS (below). The consultation proposes measures which will affect, among others, manufacturers, wholesalers, importers of medicines and NHS hospital pharmacy departments and community pharmacies. The information provided would (i) facilitate the determination of remuneration/payment of community pharmacies and GP practices, (ii)  help ensure the availability and value-for-money of health service products and (iii) support the cost control provisions in the NHS Act 2006. Draft regulations, the Health Service Products (Provision of Information and Disclosure) Regulations 2017/18 are available alongside the consultation. (JW)

Consultation on more changes to PPRS

Posted: Friday, August 25th, 2017

A consultation has been launched by the DH to amend the Pharmaceutical Price Regulation Scheme (PPRS) that controls the price of branded medicines to the NHS. This is aimed to achieve alignment with the current voluntary scheme agreed in 2014. Consultation closes on October 17th 2017 (JW)

NHS pilot to support whistleblowers

Posted: Wednesday, August 23rd, 2017

All professions require registrants to speak up when they have concerns. There have been numerous cases where staff have spoken up and it has had a detrimental effect on their work.

NHS England has announced a new pilot programme to support whistle blowers as part of their response to Sir Robert Francis’ Freedom to Speak Up report.

Details of this pilot can be found here

(MB)

Practising as a pharmacist

Posted: Tuesday, August 22nd, 2017

Some may remember the arguments about the Pharmacy Order clause which appears to suggest that doing a talk about medicines to the local WI might be classed as "practising" pharmacy. Well the GPhC seems to be offering a rather narrower interpretation in its guidance on "working in pharmacy when not on the register" to be found in the latest edition of Regulate. No comment. (JW)

New POM to P reclassifications

Posted: Thursday, August 17th, 2017

The MHRA has announced the reclassification of a number of previously Prescription Only Medicines (POMs) over recent months, adding to the range of medicines that pharmacists can supply without a prescription. The reclassifications include:

Maloff Tablets (atovaquone and proguanil)

Nasonex Allergy Control Nasal Spray (mometasone furoate)

Dovonex Psoriasis Ointment (calcipotriol)

See each hyperlink for further details (MB)

GPhC consults on guidance for the pharmacy team

Posted: Thursday, July 20th, 2017

The GPhC has launched a consultation on "Guidance for the Pharmacy Team" by which they mean, as well as registered practitioners, pharmacy owners and managers who are not pharmacists and other non-registered staff involved in pharmacy operations. This is intended to "strengthen and assure the regulatory framework for unregistered staff". The new guidance will also replace the current policy on training for dispensing/pharmacy assistants and medicines counter assistants. Consultation closes on 11th October 2017. (JW)

Lilly wins patent appeal against Actavis

Posted: Thursday, July 13th, 2017

The Supreme Court has ruled that similar Actavis products do infringe Eli Lilly's patent for permetrexed disodium (Alimta) in the UK, Italy, France and Spain. (JW)

 

GPhC Consultation on revalidation for pharmacy professionals closes 17 July 2017

Posted: Tuesday, July 11th, 2017

The GPhC consultatio on revalidation closes next Monday. Details of the consultation including information on how to provide your thoughts and feedback can be found here. (MB)

Save the date - PLEA 2018 Annual seminar and AGM date announced

Posted: Sunday, June 25th, 2017

The 2018 Annual Seminar and AGM will be held on Wednesay 16th May in London at the offices of Charles Russell Speechlys.

More details will be published nearer the date, but please save the date. (MB)

Results page: 1 2 3 4 ... 26 27 28 [Next]


These news items are not exhaustive but are selected according to their relevance to pharmacy practice, NHS community pharmacy contracts and the regulation of the pharmacy profession. If you wish to add any items that you think we have missed, contact our news editor.